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EFFECTS OF DEGRADATION ON MECHANICAL PROPERTIES OF TISSUE-
ENGINEERING POLY(GLYCOLIC ACID) SCAFFOLDS 
Y.C. Shih1 and J.D. Humphrey2 
1 Yale School of Medicine, New Haven, CT 
2 Yale School of Engineering and Applied Sciences, New Haven, CT 
 
Tissue-engineered vascular grafts (TEVGs) offer tremendous therapeutic potential for congenital 
cardiovascular malformations, and our computational model of growth and remodeling may help 
expedite TEVG design by identifying optimal scaffold parameters. To evaluate our model’s 
assumptions about scaffold physical properties, we measured the effects of in vitro hydrolytic 
degradation on the compressibility and mechanical behavior of poly(glycolic acid) (PGA) 
scaffolds. Degradation in neutral PBS at 37°C passed through two stages of first-order decay: the 
first 50 percent of PGA mass was lost from 5 to 40 days (~1 to 6 weeks) at a rate constant of 0.175 
wk-1, after which the mass degraded with a rate constant of 0.091 wk-1. The half-life of PGA 
coincided with a drop in the rate of pH change from 2.5 wk-1 to 1.5 wk-1 at 6 weeks, showing that 
the remaining mass of polymer influences the creation of acidic degradation byproducts from PGA. 
Over 25 days, the degrading scaffolds became less stiff (Young’s modulus decreased from 6.45 to 
0.12 MPa), underwent a dissipative, non-elastic process during repeated loading-unloading cycles, 
and exhibited increasing diversity of mechanical behavior that is similar to the phenotypic diversity 
manifested by 2 year-old TEVG grafts [2]. Incompressibility was maintained until day 25, possibly 
because by then the scaffolds are heterogeneously fragmented and the load is not transmitted evenly 
throughout the material. These scaffolds behave in a complex manner as they degrade in vitro, and 
more complete data are necessary to inform the next generation of computational models and to 







This work was funded by the American Heart Association Heritage Affiliate’s Medical 
Student Research Fellowship.  
Many thanks go to the Humphrey Lab for their generous guidance,  assistance, and 
inspiration, and to the Yale School of Medicine Office of Student Research for their 
support. 
No commercial entity paid or directed, or agreed to pay or direct, any benefits to any 
research fund, foundation, division, center, clinical practice, or other charitable or nonprofit 







Table of Contents 
Abstract ............................................................................................................................................ 2 
Acknowledgements .......................................................................................................................... 3 
Background & Clinical Significance ............................................................................................... 5 
Hypothesis ..................................................................................................................................... 13 
Specific Aims ................................................................................................................................. 15 
Methods ......................................................................................................................................... 15 
Scaffold fabrication .................................................................................................................... 15 
Degradation studies .................................................................................................................... 15 
Cannula preparation ................................................................................................................... 16 
Mechanical testing ..................................................................................................................... 17 
Imaging PGA scaffolds with OCT ............................................................................................. 19 
Optical strain and volume analysis ............................................................................................ 22 
Statistical analysis ...................................................................................................................... 25 
Results ............................................................................................................................................ 25 
Mass loss and pH change during scaffold degradation .............................................................. 25 
Decreasing modulus and increasing variability of scaffold behavior ........................................ 28 
Incompressibility of degrading PGA scaffolds .......................................................................... 31 
Discussion ...................................................................................................................................... 34 






Background & Clinical Significance 
Tissue engineered vascular grafts (TEVGs) offer significant promise to 
cardiovascular medicine as evidenced by the first successful human clinical trial over 10 
years ago, which used TEVGs to treat children with congenital heart defects [3]. Yet, 
development of this technology remains hindered by the time-consuming “trial and error” 
approach of tissue engineering, and stenosis remains a complication.  
Congenital cardiovascular malformations are the most common cause of infant 
death due to birth defects [4]. They represent a heavy burden in terms of morbidity, 
mortality, and healthcare costs; nearly 40,000 births per year in the United States are 
affected by congenital heart defects, and 25 percent of these children have a critical defect 
that generally requires surgery or other procedures during their first year of life [5-7]. 
Surgical management has improved greatly, but is not without risk of complications: 
thrombo-embolic events, infection, and poor durability due to neointimal hyperplasia or 
ectopic calcification [8]. Because the synthetic devices utilized in most reconstructive 
operations lack growth potential, children may require replacement surgeries as they 
outgrow their implants, which substantially increases overall morbidity and mortality [8].  
Scaffolds for tissue engineering, in contrast, resorb once they have served their 
purpose as a template for vascular regeneration. Tissue engineering aims to restore or 
replace defective tissue by creating biological substitutes; a polymeric scaffold provides 
initial structural support and biological and physical cues for tissue development, thus 
mimicking the functions of endogenous extracellular matrix (ECM). As the scaffold 




potential to grow and develop with the child. In the most recent follow-up of the first 
clinical trial of TEVGs implanted as conduits from the inferior vena cava (IVC) to the 
pulmonary artery, 25 children demonstrated low risk for thromboembolic events – the most 
common complication associated with synthetic grafts – and no signs of graft-related 
mortality or aneurysmal dilation, graft rupture, or graft infection [10] (Figure 1). The 
primary mode of graft failure was stenosis in four patients who were successfully treated 
by balloon angioplasty. Clinical experience thus far affirms the overall safety and efficacy 





Although the clinical utility of TEVGs is promising, little is known about how these 
polymeric constructs transform into living blood vessels in host recipients. Our findings 
Figure 1: CT scan of a TEVG 
implanted in a child, connecting 
the IVC to the pulmonary artery, 
three years post-implantation 
(modified Fontan procedure for 
congenital single ventricle 
physiology). Note that there is no 




have suggested that circulating host monocytes release myriad inflammatory cytokines and 
growth factors, recruiting macrophages and cells from the surrounding native vessel and 
perivascular tissue to migrate into the polymer scaffold [11, 12]. This inflammatory 
response will dictate the graft’s success or failure, and the scaffold’s material 
characteristics – chemical, physical, and morphological – play an important role in 
modulating cellular events and their path towards normal or pathological wound healing 
[13]. For example, hydrophilic surface chemistries decrease in vivo expression of 
inflammatory cytokines by surrounding immune cells [14]. Macrophages, the most 
important component of innate immunity, may shift to a pro-inflammatory (M1) or pro-
healing (M2) subtype depending on the surface micro-pattern, material morphology, fiber 
diameter, and pore size [14-17]. Fibroblasts preserve collagen homeostasis by sensing 
mechanical stimuli and changing their phenotype accordingly; exposure to a substrate that 
is stiffer than their physiological environment will activate a myofibroblast phenotype that 
simultaneously exhibits contractile activity and high matrix secretion [18, 19]. Many other 
physico-chemical properties also influence tissue remodeling (see Table 1 for more 
examples), but understanding the full extent of their effects remains a challenge, 
particularly when scaffold degradation enters the picture.  
As the primary immunological stimulus and initial source of structural integrity, 
the scaffold determines multiple aspects in the growth and remodeling process, and it is 
crucial that we understand how these change as the polymer degrades. The poly(glycolic 
acid), or PGA, polymer used in our venous TEVG scaffolds has been approved for 
biodegradable medical devices since the late 1970s, but reports on its degradation profile 




in as little as two to four weeks [21], whereas others report that PGA sutures are not 
completely resorbed until about four months although they lose 70 percent of their 
mechanical strength within two weeks of implantation [20]. In our own venous grafts, 
Naito and colleagues reported that half of the PGA volume was lost when explanted at two 
weeks, and nearly no scaffold was detected at 12 weeks when measured with polarized 
light or Masson’s trichrome staining [22]. What happens to the polymeric scaffold during 
the interval between those time points is unknown. This gap in our knowledge – as well as 
the inconsistency in literature - calls for further investigation about scaffold degradation 





Table 1: Select scaffold physico-chemical properties are listed above after an extensive 
literature search for primary drivers of vascular growth and remodeling [13, 16-18, 23-







as the scaffold degrades and gives rise to neotissue, it is thought that the cells transition to 
mechano-sensing and secrete and remodel matrix in response to mechanical stresses [27]. 
 
Using computational modeling, it is possible to predict macroscopic mechanical 
properties of the scaffold based on microscopic design parameters. Predictions obtained by 
a good mathematical model can provide valuable insight into optimal properties of the 
scaffold. That is, by comparing predictions with experimental findings, we can better 
identify contributions of individual constituents to the overall mechanical behavior of the 
scaffold. Whereas current endeavors in tissue engineering mainly occur by “trial and error” 
experimentation, time-efficient parametric studies enable a rational approach to designing 
TEVGs. Reducing the experimental search space with input from computational models 
may help advance our search for optimal combinations of scaffold structure and material 
properties [10, 28, 29]. Yet, such computational models must be informed by reliable data, 
and there is currently scant information in the literature on the biomechanical behavior of 
a degrading polymer scaffold. O’Dea and colleagues used a multiphase continuum 
framework to study the interplay between in vitro tissue growth and scaffold degradation, 
albeit within the limited settings of a fspecially designed perfusion bioreactor [30]. Soares 
and Moore, and later Vieira and colleagues, proposed a neo-Hookean model that 
reasonably approximates, but does not accurately simulate, how the polymer responds at 
each stage of degradation [31, 32].  
Novel innovations by our group have paved the way for creating second-generation  




techniques for fabricating scaffolds having different mechanical and structural properties 
[11, 33] enable model suggested physical parameters to be tested experimentally; a 
miniaturized TEVG for in vivo studies in diverse transgenic murine models [33] enables 
detailed longitudinal studies to test graft efficacy; a custom computer-controlled biaxial 
testing system, designed specifically for testing mouse vessels, enables us to collect novel 
biomechanical data on the evolution of TEVG properties (Figure 2A); and,  development 
of a first-generation computational model for TEVGs that accounts for polymer 
degradation kinetics and the synthesis and degradation of primary structural components 
enables data-driven, time-efficient parametric studies (Figure 2B) [22, 28, 34-36]. 
Capitalizing on these advances, one of our primary goals is to understand neovessel 
formation as a sequence of inflammation-mediated followed by mechanobiological 
processes involving host cells that result in a replacement conduit having near native 
properties, including growth potential [11, 12]. Toward this end, biomechanical properties 
of patent versus stenotic inferior vena cava (IVC) interposition grafts were quantified in 
two murine models – wild type (C-17) and immunodeficient-beige (SCID-bg) – which 
exhibit significantly different rates of TEVG stenosis [10, 22]. Using these data, we then 
extended a prior growth and remodeling computational model for native vessels to 
incorporate the monotonic loss of load bearing capability by the polymeric scaffold, the 
inflammation- and mechano-mediated production of collagen, and the evolution of 






Figure 2: (A) Measured pressure-diameter curve for actual TEVGs over 6 months of 
implantation; note its similarity to IVC compliance by 24 weeks [22]. (B) Predicted 
changes in circumferential wall mechanics over time for a collagenous TEVG [18]. 
 
This extended model depicts many of the salient mechanical features of an evolving 
TEVG, but it is only a first-generation model, and many of its assumptions need to be 
evaluated with more complete data – in particular, the assumption that the mechanical 
properties of the polymeric scaffold could be described by a neo-Hookean behavior [36]. 
We thus developed a separate computational model (Matlab program) to model the 
mechanics of our polymer scaffold over the course of its degradation, guided by neo-
Hookean models in the literature [31, 32], and verified its implementation via numerical 
simulations. However, because this incompressible material model failed to describe our 
initial set of experimental data on polymer degradation (Figure 3), we were not able to 
confirm prior assumptions by others on polymeric scaffold physical properties – i.e., 
incompressibility (volume does not change when material is subjected to stress) and 









Figure 3: Pilot result predictions by our initial neo-Hookean model (blue line) were not 
consistent with experimental data on scaffold degradation (red +’s). 
 
It is possible that the scaffold exhibits an evolving compressible behavior due to 
changes in porosity, or that the original scaffold testing protocol and data analysis needed 
to be refined. Additionally, the simple sigmoidal decay that we assumed for the scaffold 
may not accurately reflect the time-course of degradation. These assumptions needed to be 
re-evaluated and the constitutive relations modified accordingly if the scaffold is 
compressible (e.g., Blatz-Ko).  
As of yet, there exists insufficient experimental data to confirm the key assumptions 
about scaffold physical properties in our computational model of in vivo TEVG 
development. Likewise, we know little about the degradation profile of our polymeric 
scaffold. In vitro degradation studies of PGA scaffolds can provide a reasonable 




separating partially degraded scaffold from regenerated tissue, and the data obtained for 
PGA scaffolds in buffer have been proven to match the calculation of polymer degradation 
in cell-PGA constructs [37]. Freed and colleagues seeded nonwoven PGA meshes with 
chondrocytes and accurately predicted the total cell-polymer construct mass by summing 
the products of cellular accumulation (cells, glycosaminoglycans, and collagen measured 
in cell-polymer constructs) with scaffold degradation (the mass of the remaining PGA 
measured from their in vitro degradation study) [37]. Also, PGA fibers will degrade 
similarly in neutral phosphate-buffered solution (PBS) at 37°C as they would in vivo in 
extracellular fluid; bulk hydrolysis is the main degradation mechanism for PGA fibers, 
meaning that the fibers erode both inside and on the surface, independent of surface-to-
volume ratio [38]. Herein, we report the effects of in vitro hydrolytic degradation on the 
mechanical behavior of cylindrical scaffolds composed from nonwoven PGA fibrous felt, 
as well as a novel method for assessing the compressibility and real-time changes in 
scaffold dimensions during mechanical testing.  
 
Hypothesis 
There is a well-established connection between intimal hyperplasia and synthetic 
vascular grafts that alter the mechanical stresses experienced by the host vessel [39]. This 
phenomenon appears to result from changes in gene expression that vascular cells undergo 
in response to perturbations in mechanical stimuli – for example, biomechanical effects of 
compliance mismatch between graft and native vasculature [40, 41]. We hypothesize that 




promote mechanical homeostasis throughout the remodeling process, and that by matching 
the evolving compliance of the graft with that of the host vessel, we may decrease the 
incidence of TEVG stenosis. We hypothesize further that inflammation mediates the early 
maturation phase of TEVGs into fully functional vessels in vivo, which involves both 
innate and adaptive components of the immune system. Monocytes and macrophages 
appear to initiate an inflammatory cascade that recruits cells from adjacent native vessel 
and forms neotissue at the graft site, analogous to postnatal neovascularization [11, 12]. T 
cells, the main actors in adaptive immunity, also influence postnatal neovascularization 
[42]. We hypothesize that the changing mechanical and material behavior of the degrading 
scaffold will cause corresponding changes in ECM production by immune and vascular 
cells, ultimately reflected by the TEVG’s mechanical behavior.   
Our overall goal is to construct a validated, predictive computational model that 
enables time-efficient parameter sensitivity studies that identify ways to improve the 
functional compatibility between the graft and host vessel, thus expediting the development 
of advanced TEVGs by rational design. Toward that end, the purpose of this study is 
threefold: to evaluate the assumptions about scaffold physical properties in our first-
generation growth and remodeling computational model, to collect the experimental data 
needed to inform the next generation of computational models, and to develop and validate 
a novel method of measuring real-time changes in scaffold geometry – both inside and on 







• Evaluate the evolving mechanical properties of PGA scaffolds undergoing in vitro 
hydrolytic degradation.  





Tubular TEVG scaffolds were constructed by Cameron Best (Nationwide 
Children’s Hospital, Columbus, OH) from sheets of nonwoven poly(glycolic acid) (PGA; 
Concordia Fibers, Coventry, RI) that were wrapped around a 21G needle, placed in a 20 
μm-diameter mold, and sealed with a 50:50 copolymer of ε-poly(caprolactone) and L-
poly(lactide) (P[PC/LA]; Absorbable Polymers International, Birmingham, AL). Scaffolds 
ranged from 3 to 3.5 mm long with an inner diameter of ~700 to 800 μm and a wall 
thickness of ~290 to ~360 μm. Specifications given by Concordia Fibers for the nonwoven 
PGA fiber felt sheets include: polymer specific gravity 1.5 - 1.7 g/cm3; felt density 150 
mgr / cm3; PGA fiber diameter ~14 - 16 μm; felt thickness ~0.3 mm.  
 
Degradation studies 
Dry scaffolds were weighed to record their initial masses and incubated at 37 ºC in 




Grand Island, NY). Every week for 10 weeks, the pH of the medium was measured 
(Accumet AP71 pH/mV/C meter, Fisher Scientific, Waltham, MA) and PBS was replaced 
to maintain pH between 7.0 and 7.1 inside the micro-tubes, replicating how blood flow 
removes degradation byproducts and prevents the micro-environment pH from becoming 
overly acidic. Change in pH (∆pH) per week was calculated as: 
∆𝑝𝑝𝑝𝑝 =  𝑝𝑝𝑝𝑝 − 7.0 
where pH is the instantaneous pH at time of measurement. 
One set of scaffolds (n = 5) was removed at timed intervals of 5 days for over 40 
days, and then at intervals of 7 days for 4 more weeks. Scaffolds were dried by 
lyophilization and re-weighed to calculate the dry mass ratio, 








Cannula used for mounting the scaffolds during testing were prepared by crimping 
and roughing the ends of 21G needles with sand-paper to prevent slippage; the scaffolds 
were then mounted and tightly secured to the cannula with 7-O silk tie suture. India ink 
was used to mark the scaffold at least one-diameter length away from each cannulated end 
so that the effects of tying (e.g., axial variations in strain) are minimized according to Saint-




and couple at the end will not alter the expected stress or strain at distances remote from 
the point where load is applied (i.e., tied ends of scaffold) [43]. 
 
Mechanical testing  
PGA scaffolds were removed from the incubator and subjected to uniaxial tensile 
loading every 5 days over 4 weeks (n = 5 at every time point). Mechanical testing occurred 
under semi-biomimetic conditions – in PBS at 25° C – since polymers are viscoelastic and 
exhibit time-dependent behavior that will change with temperature, loading rate, and wet-
versus-dry state [44-46]. There is a clear decrease over time in mechanical properties from 
dry to wet states once polyester scaffolds have been wetted in PBS for 0.5 hours, but their 
properties remain stable and do not diminish significantly from 0.5 to 24 hours after being 
hydrated [47]. Therefore, the PGA scaffolds were immersed in PBS for 30 minutes before 
testing.   
Due to the porous nature of the PGA felt, the scaffolds could not hold pressure in 
our bi-axial mechanical testing system; hence, a custom mechanical testing system was 
designed in SolidWorks CAD software (Dassault Systèmes S.A., Vélizy-Villacoublay, 
France) and built to incorporate a VMS-001 micro-camera (Veho, Hampshire, United 
Kingdom) and ThorLabs Callisto OCT system (Thorlabs, Inc., Newton, NJ) (Figure 4A). 
The specimen was immersed in a fluid bath containing PBS, with one cannula fixed to the 
bath wall and the other attached to weights via a pulley system (Figure 4B).  
Quasi-static loads were imposed in increasing increments of 10g until the scaffold 




scaffold became fragile due to degradation, it was loaded in 2g increments until it 
experienced plastic deformation. After five cycles of tensile testing – three of which are 
preconditioning, following the mechanical testing protocol of Klouda et al [46] – one intact 
scaffold from each time-point group underwent an additional cycle in which the inner and 
outer radii at each loading step were measured by OCT. For this sixth cycle, the scaffold 
was immersed in glycerol rather than PBS to accommodate the limitations of OCT imaging 
(discussed further below). To eliminate air trapped inside the pores, scaffolds were first 
evacuated of all air and then immersed in glycerol while maintaining vacuum.  
 
Figure 4: (A) Mechanical testing set-up. Real-time changes in scaffold dimensions are 
captured by the VMS-001 micro-camera and ThorLabs Callisto optical coherence 





Figure 4: (B) During uniaxial tensile testing, the scaffold is immersed in PBS at room 
temperature (25°C) inside the fluid chamber. When visualizing the scaffold under OCT, the 
chamber is filled with glycerol and the air within the scaffold evacuated. 
 
 
Imaging PGA scaffolds with OCT 
Optical coherence tomography (OCT), similar in concept to ultrasound, uses beams of 
infra-red light to image cross-sectional slices of a sample and build 3D reconstructions. 
Unlike scanning electron microscopy, it can visualize changes in real-time on the 
microscopic scale and does not destroy the sample [48]. However, certain technical 
challenges initially limited its ability to image our PGA/PCL scaffolds: (1) the Callisto 
OCT system cannot visualize pore sizes smaller than 7 μm (its maximum resolution); (2) 
refractive index mismatch between PGA and PBS necessitated the search for a superior 
imaging solvent; and (3) complex pore geometry trapped air inside the scaffold, 




(Figure 5). Pure glycerol proved to be the most suitable, cost-effective imaging solvent 
after experimenting with PBS, ethanol, and water in various ratios. Glycerol has a 
refractive index (1.47) similar to that of PGA (1.45 – 1.51), and it is a safe solvent for OCT 





Figure 5: (A) OCT uses infrared light to capture cross-sectional slices and build 3D 
reconstructions. (B) Refractive index mismatch and complex pores that trap air make 
scaffolds difficult to image with OCT in liquids with low refractive index (e.g., water, PBS, 
or ethanol).  (C) Placing scaffolds under vacuum to evacuate air from the pores, followed 
by immersion in glycerol, vastly improves image quality. Note that the decrease in inner 






The reverse order – complete immersion in fluid, followed by de-gassing – had less 
of an effect, possibly because this adds another air-fluid interface and thereby increases the 
capillary pressure that the vacuum must generate. Our procedure requires one outlet for air 
and one inlet for glycerol; most commercial vacuum chambers contain only one port, 
however; thus we built a custom vacuum chamber with two ports. Pilot studies did not 
show a significant difference between the mechanical behavior of scaffolds in glycerol or 
PBS (Figure 6) and no significant difference in thickness before and after immersion 
(Figure 7), making glycerol an acceptable solvent for imaging the scaffold under OCT 
during tensile tests. 
 
 
Figure 6: There is no significant difference in mechanical behavior between scaffolds 





Figure 7: No significant swelling of the PGA nonwoven fiber felt is visible on OCT before 
and after immersion in glycerol for 20 minutes (277.4 um ± 7.97 vs. 261.9 um ± 4.19, p < 
0.05). 
 
Optical strain and volume analysis  
The VMS-001 micro-camera and the Callisto OCT acquired real-time images at 
each loading step. ImageJ software (National Institutes of Health, Bethesda, MD) was used 
t = 0 min 




to quantify the scaffold thickness from OCT images, the outer diameter from micro-camera 
photos, and the length from the distances between India ink marks. 
To quantify the mechanical properties of the scaffold, we needed to compute the 
applied axial stress and resulting extensional strain. Stress is a measure of applied force 
acting over a cross-sectional area; strain is a non-dimension measure of the change in 
length. The force (F) applied to the scaffold during uniaxial testing was computed from the 
applied mass (m), in grams, multiplied by the gravitational constant g times a correction 
factor (c) that accounted for the friction within the pulleys used in the uniaxial tension tests. 
That is, 𝐹𝐹 = 𝑚𝑚𝑚𝑚 ∗ 𝑐𝑐 . To find this correction factor, we used Hooke’s law for a metallic 
calibration spring, which states that force (F) is proportional by a spring stiffness (k) to 
extension (x) of a spring: 𝐹𝐹 =  𝑘𝑘𝑘𝑘. The correction factor (c) was the original stiffness (k0) 
for a metal spring (loaded only with weights) divided by the altered spring stiffness (k1) 
(the spring was loaded in the pulley system): 






=  1.1076  
The extensional strain experienced by the scaffold is determined easily from the 
axial stretch (λ), which is calculated as the ratio between the current length and the original 
unloaded length: 




The volume of the polymer at each load was estimated based on the cross-sectional area at 




𝑉𝑉 = 𝐿𝐿�𝜋𝜋(𝑅𝑅2 − 𝐷𝐷2)� 
where R and r denote outer and inner radii, respectively. 
Finally, engineering stress (σe) and strain (εe) were based on the original cross-
sectional area (A0) and unloaded length (L0) of the cylindrical scaffold: 








where ΔL = L - L0. Alternatively, true stress (σt) and strain (εt) were calculated using the 
instantaneous cross-sectional area (A) at the time of loading and the natural logarithm of 
instantaneous axial stretch (i.e., the instantaneous length of the specimen, L, divided by the 
initial length, L0). 
𝜎𝜎𝑡𝑡 =  
𝐹𝐹
𝐴𝐴 




Young’s modulus (E) was the slope at the linear portion of the engineering stress-strain 
curve in the 5-30% strain range: 







Stress-strain curves were smoothed with a moving average filter, normalized by 
dividing all length measurements by the minimum length, and presented as mean ± 
standard deviation (SD). All other data were represented as mean ± SD. All other 
comparisons between groups were performed using a Student׳s t-test. P-values <0.05 were 





Mass loss and pH change during scaffold degradation 
The degradation of nonwoven PGA fiber scaffolds in neutral PBS at 37°C passed 
through two stages of first-order decay (Figure 8 and Table 2). The first 50 percent of 
PGA mass decreased from 5 to 40 days (~1 to 6 weeks) with a rate constant of 0.175 wk-1, 
after which the mass degraded with a rate constant of 0.091 wk-1. After 10 weeks in vitro, 
the PGA had degraded to less than 30 percent of its initial mass, similar to results reported 
by Freed et al. [37]. 
The pH curve is represented as the weekly change in pH from pH 7.0 (Figure 8 and 
Table 3). Acidic degradation byproducts may cause autocatalysis and thereby hasten the 
rate of polymer degradation, so in an effort to mimic the in vivo removal of glycolic acid 
byproducts from the TEVG by blood flow, the PBS was replaced weekly to maintain a pH 
of 7.0-7.1 around the scaffolds [26]. The highest change in pH occurred between 3 and 6 




in pH change, just as PGA mass degradation enters its slower period of degradation. This 
correlation shows how degradation depends on polymer mass; when only 50 percent of the 




Figure 8: Dry mass ratio (left axis, mean ± SD) and change in pH per week (right axis, 
mean ± SD). PGA mass follows two stages of first-order decay. The half-life of PGA 
degradation is 5-6 weeks, coinciding with a decrease in the rate of change in pH. Change 
of pH (∆pH) per week is calculated with respect to pH 7.0 because the PBS was replaced 
weekly to return the medium to neutral pH (i.e., minimize autocatalysis).  Thus, ∆pH of 3 
at 21 days means that the production of acidic degradation byproducts from PGA scaffolds 




Table 2: Dry mass ratio versus degradation time (mean ± SD).  
 
Days Dry Mass Ratio SD 
0 1.000 0.000 
5 0.989 0.015 
10 0.918 0.092 
15 0.757 0.075 
20 0.663 0.073 
25 0.594 0.031 
30 0.525 0.057 
35 0.496 0.083 
40 0.426 0.043 
47 0.373 0.047 
54 0.331 0.009 




Table 3: Change in pH from neutral pH per week (mean ± SD). PBS in the micro-tubes 










Days ∆pH (from neutral pH) SD 
0 0.00 0.05 
7 0.21 0.03 
14 1.58 0.28 
21 3.06 0.32 
28 2.92 0.32 
35 2.75 0.39 
42 2.56 0.24 
49 1.53 0.24 
56 1.24 0.02 
63 1.21 0.14 




Decreasing modulus and increasing variability of scaffold behavior 
  As the PGA scaffolds degraded, the Young’s modulus decreased and the 
mechanical behavior of the scaffolds also became increasingly variable, as evidenced by 
the widening of the standard deviation error bars (Figures 9 – 11 and Table 4). There 
appeared to be three subsets of mechanical behavior: from 0 to 5 days, the scaffolds were 
stiffest as expected; on days 10 and 15, the modulus decreased with a concomitant drop in 
yield strength, losing nearly half by day 15; and by days 20 and 25, the scaffolds had lost 
more than 90 percent of their mechanical strength and exhibited plastic deformation. Prior 
to day 15, the scaffolds were fairly robust. On day 15 and afterwards, however, the fragile 
scaffold required careful handling; it would separate into fiber “fragments” when loaded 
or sometimes the proximal and distal fragments would shift under tension, whereas 
unconnected fibers in the middle appeared to not move. These variable behaviors increased 
the difficulty of mechanical testing because the load was not distributed homogenously 
throughout the entire scaffold structure, and the tracking markers had to be precisely placed 
on fragments that moved. The fragmentation is most likely because the scaffold is 
composed of non-woven PGA fibers that are matted together, but not necessarily all linked 
physically. In the day 20 group, it also became apparent that the seam line is a weak point; 
scaffolds were more degraded and failed more often at the seam line. 
  Hysteresis – the energy dissipated by the material while loaded and unloaded - 
grows larger on the first testing cycle (preload) as the scaffold is degraded from 0 to 10 
days, possibly because hydrolysis has broken enough ester bonds to render the PGA more 




configuration after unloading. There are no hysteresis curves shown for the time points 
after day 10 because the scaffolds have weakened and plastically deform instead. 
 
 
Figure 9:  Load vs. axial deformation. With increasing degradation time, Young’s modulus 
decreases, i.e., the scaffolds become less stiff, and the mechanical behavior of the scaffolds 
becomes increasingly variable, as evidenced by the widening standard deviation error 
bars. 
 
Days Young’s modulus (MPa) Correlation coefficient 
0 6.449 0.997 
5 5.346 0.991 
10 2.571 0.999 
15 2.014 0.997 
25 0.120 0.998 





Figure 10: Engineering stress vs. strain of PGA scaffolds over degradation time.  
 




Figure 12: Hysteresis on preload (the first testing) cycle grows larger with time of 




Incompressibility of degrading PGA scaffolds 
PGA scaffolds remain relatively incompressible through most of the degradation and their 
volume stays constant during loading, except at day 25 when the compressibility seems to 
manifest (Figure 13). This transition may be attributed to the fact that the scaffolds are 
heterogeneously fragmented by this time; the load will not be transmitted evenly 
throughout the material, hence an axial extensional strain will not necessarily cause a 
transverse compressive strain (i.e., true Poisson effect), and the outer diameter of the 























do decrease over time, however, as expected (Figure 14).
 
Figure 14: PGA scaffolds remain relatively incompressible through most of degradation, 
i.e., volume stays constant during loading, except at day 25 when the polymer scaffold’s 
volume seems to increase during loading.  This may be attributed to the fact that the 
scaffolds are heterogeneously fragmented and the load is not transmitted evenly 
throughout the material. Hence, a positive tensile strain will not contribute a negative 
compressive strain in the lateral direction, and the outer diameter of the fragmented 







Figure 14: More than half of the scaffold volume (A) and cross-sectional area (B) is lost 







Herein we report the effects of in vitro hydrolytic degradation on the mechanical 
behavior of cylindrical tissue engineering scaffolds composed primarily of a nonwoven 
PGA fibrous felt, as well as a novel method for assessing the compressibility and real-time 
changes in scaffold dimensions during uniaxial mechanical testing. As an aliphatic (open 
chain, non-aromatic) polyester, PGA degrades in an aqueous environment primarily 
through bulk erosion; hydrolytic attack cleaves the ester bond backbone, causing random 
chain scission on both the surface and the inside of PGA fibers [20, 50]. Autocatalysis can 
occur inside the core of the material due to acidic degradation byproducts trapped within 
the substrate. By attempting to control this effect and keep the medium at a neutral pH, we 
collected and analysed experimental data that correlate changes in pH – an important 
determinant of degradation rate – with PGA mass loss in the two stages of a first-order 
exponential decay. This study found a PGA in vitro half-life of 6 weeks, whereas Naito 
and colleagues report that PGA lost half its volume in vivo in just 2 weeks [22]. Proteolytic 
activity as part of the in vivo foreign body response could be responsible for this 
discrepancy, and there exists evidence that various enzymes like carboxypeptidase A can 
increase the rate of PGA hydrolysis [20].   
Scaffold degradation adds another layer of complexity to computational modeling. 
Intuitively, the scaffold’s changing mechanical and material behavior will drive 
corresponding adaptations in the immune and vascular cells responsible for neovessel 
development. Importantly, the rate of tissue regeneration should match polymer 




acute inflammation-mediated to the mechano-biological dominated production of matrix, 
as shown by the highly stiff poly(lactic acid), that is PLA, aortic TEVGs which showed 
signs of chronic inflammation secondary to inadequate in vivo degradation of PLA [27]. 
Khosravi and colleagues discovered that phenotypic diversity manifested via two sub-
groups of 2 year old grafts, characterized with two different compliances, despite all 
procedures being the same, and that increased variability of experimental data at 24 weeks 
and 2 years could be simulated by changing two model parameters – mechano-mediated 
collagen material properties and the half-life of collagen produced during inflammatory 
period [2]. Perhaps another contributing factor to the increased variability of TEVG data 
at two years could be the increasing heterogeneity of scaffold behavior due to degradation; 
as the polymer scaffold degrades over time, its loss of structural integrity will influence its 
mechanical contribution and hence its overall effect on the remodeling process, including 
collagen deposition. 
We have taken a step forward in characterizing the effects of hydrolytic degradation 
on the mechano-physical properties of venous polymeric scaffolds, and our results show 
that the PGA scaffolds are indeed incompressible up until 25 days of degradation. 
However, more complete data are necessary to evaluate assumptions in our first-generation 
model and to illustrate clearly the evolving mechanical behavior of polymeric scaffolds. 
The degrading PGA scaffolds do not return to their original configuration after pre-loading, 
and it is not clear what is giving rise to such complex physical behavior. The reason could 
be on a molecular level – breaking of secondary bonds, internal sliding and friction of 
macromolecular polymer chains, physical entanglements of fibers, or the large-scale 




the scaffold is a blend of polymers – PGA coated with PCL - it is also a candidate for the 
Mullins effect, which is an irreversible softening of the stress-strain behavior whenever the 
load increases beyond its prior maximum value [44]. No matter the cause, the polymer 
behaves in a complex manner as it evolves in vitro, and this dissipative, non-elastic process 
must be taken into account in any computational model. 
There clearly remains a pressing need for further investigations of scaffold 
properties and their interactions with matrix production by immune and vascular cells. The 
processes underlying vascular growth and remodeling must be further elucidated in order 
to develop therapeutic interventions against graft stenosis or dilation, and to build a 
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